Engineers Gate Manager LP

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1620220 NEW YORK, NY

Position in ALLO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$258,432

+$213,239 QoQ

Shares Held

105,915

+190.6% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Engineers Gate Manager LP holds $239,656,316 across 145 Biotechnology names. ALLO ranks #106 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	158,792	$25,965,667
2	BMRN	Biomarin Pharmaceutical Inc	436,860	$24,678,221
3	BBIO	BridgeBio Pharma, Inc.	243,729	$18,099,315
4	JAZZ	Jazz Pharmaceuticals plc	92,990	$17,579,759
5	ALNY	Alnylam Pharmaceuticals, Inc.	32,502	$10,753,936
6	IONS	Ionis Pharmaceuticals Inc	133,827	$10,049,069
7	TVTX	Travere Therapeutics, Inc.	254,401	$7,558,253
8	ROIV	Roivant Sciences Ltd.	256,447	$7,103,581

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$258,432	105,915	+190.6%	Shares	Sole	2026-05-15
2025-09-30	$45,193	36,446	+12.3%	Shares	Sole	2025-11-14
2025-06-30	$36,685	32,465	-32.0%	Shares	Sole	2025-08-14
2024-09-30	$133,764	47,773	-50.1%	Shares	Sole	2024-11-14
2023-06-30	$475,857	95,746	-5.5%	Shares	Sole	2023-08-14
2023-03-31	$500,743	101,365	-25.0%	Shares	Sole	2023-05-15
2022-12-31	$849,646	135,079	+180.6%	Shares	Sole	2023-02-14
2022-09-30	$519,955	48,144	+139.5%	Shares	Sole	2022-11-14
2021-12-31	$299,966	20,105	-8.5%	Shares	Sole	2022-02-14
2021-06-30	$573,238	21,980	+123.6%	Shares	Sole	2021-08-16
2021-03-31	$346,999	9,830	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.